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with spheroids caused by CSF1R p.Arg782His
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Abstract
Hereditary diffuse leukoencephalopathy with spheroids (HDLS) presents with a variety of clinical phenotypes
including motor impairments such as gait dysfunction, rigidity, tremor and bradykinesia as well as cognitive deficits
including personality changes and dementia. In recent years, colony stimulating factor 1 receptor gene (CSF1R) has
been identified as the primary genetic cause of HDLS. We describe the clinical and neuropathological features in
three siblings with HDLS and the CSF1R p.Arg782His (c.2345G > A) pathogenic mutation. Each case had varied
motor symptoms and clinical features, but all included slowed movements, poor balance, memory impairment and
frontal deficits. Neuroimaging with magnetic resonance imaging revealed atrophy and increased signal in the deep
white matter. Abundant white matter spheroids and CD68-positive macrophages were the predominant pathologies in
these cases. Similar to other cases reported in the literature, the three cases described here had varied clinical phenotypes
with a pronounced, but heterogeneous distribution of axonal spheroids and distinct microglia morphology. Our findings
underscore the critical importance of genetic testing for establishing a clinical and pathological diagnosis of HDLS.
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Background
Hereditary diffuse leukoencephalopathy with spheroids
(HDLS) is a rare, autosomal-dominant neurodegenera-
tive disease that presents with diverse phenotypes in-
cluding motor impairments such as gait dysfunction,
rigidity, tremor and bradykinesia along with cognitive
impairments like personality changes and dementia [1].
The onset of symptoms is usually in the fourth or fifth
decade, progressing to dementia and death within 5–10
years. Magnetic resonance imaging (MRI) typically shows
patchy cerebral white matter abnormalities [2]. A definite
diagnosis of HDLS requires pathology demonstrating
widespread myelin loss and abundant axonal spheroids.
Since the discovery of mutations in the colony stimulating
factor 1 receptor gene (CSF1R) that are pathogenic for
HDLS [3], genetic screening of CSF1R has increased the
number of individuals diagnosed with HDLS [4–9]. Here
we describe the clinical and neuropathological features of
three siblings with a previously published pathogenic
CSF1R mutation, p.Arg782His [1].
Genetics
Targeted next-generation sequencing was performed
alongside histology, immunohistochemistry and micro-
scopic analyses of the brain tissue [10]. A heterozygous mis-
sense mutation c.2345G >A (p.Arg782His, rs282860281)
was identified in exon 18 of CSF1R (Fig. 1) in all three
symptomatic siblings (Fig. 2). Other neurodegenerative
disease-associated gene mutations were excluded and the
mutation was confirmed by genotyping using a custom
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TaqMan allelic discrimination assay (Life Technologies).
The family history is notable for late-onset dementia
in the mother at the age of 89 (Fig. 2) and a father
who died at age 62 of unrelated causes. Of note, a pa-
ternal first cousin once removed may have had symp-
toms similar to Case #1 (not shown in pedigree). The
genetic status of four additional living siblings shown
in the pedigree is not provided for privacy reasons.
Because of the father’s relatively early death and the
fact that neither parent’s DNA was available to test,
the penetrance of the mutation cannot be fully
assessed.
Fig. 1 CSF1R protein domain and mutation schematic. Schematic diagram of the protein domain structure of CSF1R with amino acid numbers
provided. Mutations previously reported in other studies are shown in black [3–5, 7–9] and the R782H mutation identified in the present study is
highlighted in red. Ig: Immunoglobulin domains
Fig. 2 Family Pedigree. A three-generation pedigree of the family is shown. The symbols for individuals symptomatic with any form of dementia
are filled with blue circles. Deceased individuals have a slash mark with age at death (d.) indicated. Diamond shapes are intended to mask gender
for privacy protection. A number within a pedigree symbol indicates the number of additional individuals in that generation
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Case presentations
All three cases presented with slowed movement, poor
balance and cognitive deficits (Table 1). Gait distur-
bances included retropulsion and postural instability,
without tremor, rigidity or cog-wheeling. Early behav-
ioral changes included impulsiveness and disinhibition.
MRIs from the three patients were reviewed by several
neurologists with expertise in neurodegenerative diseases
as well as neuroradiologists. The most consistent finding
was increased signal on FLAIR and T2-weighted images
in the periventricular and deep white matter; volumetric
measurements were not available. Ultimately, the MRI
findings were supportive of, but not distinctive for,
HDLS, although the MRI pulse sequences were not opti-
mized for the detection of calcifications and other
distinctive markers. Case #1, a female in her late 40s,
developed depression and difficulty with cognition in
addition to motor impairments, and was unable to work
after approximately one year. She was noted to be
increasingly emotionally labile. Examination at age 52
demonstrated a pseudobulbar affect. Her short-term
memory was only mildly impaired, but she exhibited
poor emotional regulation, perseveration and a deficit in
set-shifting. For example, she was unable to perform the
oral version of the Trail Making Test on which she was
required to produce an ascending sequence of alternat-
ing letters and numbers (e.g., A-1-B-2…). Clinically, she
was thought to have frontotemporal degeneration
(FTD). Case #2 was a woman in excellent health until
age 55. When first evaluated neurologically both mild
memory problems and limited use of her left hand were
noted. Her personality and behavior were mildly altered
in that she was slightly labile emotionally. Examination
demonstrated normal cognition except for a moderate
impairment in short-term word memory. She had clear
but subtle parietal deficits including left visual extinction
and a mild left motor neglect manifested as failure to
use her left arm unless instructed to do so. There was a
mild decrease in left hand dexterity. Her clinical diagno-
sis was corticobasal syndrome (CBS). Case #3 was a man
who presented with symptoms that began in his early
50s. He was found to have poor judgment at work and
trouble balancing his checkbook. He became disabled
after two years. On examination he exhibited prominent
frontal deficits including distractibility, perseveration
and mild emotional lability. Memory and visuo-spatial
Table 1 Clinical characteristics of individuals with the CSF1R p.Arg782His mutation
Case Sex Origin Onset age Age at death Initial symptoms Affected family members Prominent pathology
1a F USA late 40’s 56 Cognitive decline, depression,
slowed movement
3 siblings Severe dorsolateral frontal white matter
loss, disrupted axons, axonal spheroids
2a F USA 54 57 Poor balance, cognitive and
memory decline, slowed
movement
3 siblings Severe orbital frontal white matter loss,
disrupted axons, axonal spheroids
3a M USA early 50’s 55 Poor balance, cognitive decline,
slowed movement
3 siblings Severe orbital frontal and parietal white
matter myelin loss, disrupted axons,
axonal spheroids
4 F Japan 51 - Cognitive decline, aphasia,
epileptic seizures
3 uncles, cousin Disrupted axons, axonal spheroids (biopsy)
5 F USA 51 - Cognitive and memory decline 3 aunts Disrupted axons, axonal spheroids (biopsy)
6 F Korea 37 42 Poor balance, stuttering, dysarthria sibling, mother, uncle Frontal and parietal white matter myelin
loss, disrupted axons, axonal spheroids
aCases reported in this study
Fig. 3 Axonal spheroids were heterogeneously distributed throughout the subcortical white matter across all three subjects. Lateral
representations display the relative burden of the subcortical white matter spheroid pathology as density measurements for Cases #1-3 that are
mapped to different cortical regions (a-c respectively). Densities of the APP positive spheroids were obtained from counts and surface areas
generated by white matter regions of interest in NIH’s ImageJ 1.49. Dark grey areas indicate regions where densities were not obtained
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function were poor, with left visual extinction. By MRI,
there was thinning of the corpus callosum which was
not clearly evident in the other subjects. Clinically, his
diagnosis was dementia with Lewy bodies (DLB) and
parkinsonism. In all three instances, cognitive/behavioral
and motor deficits worsened slowly and relentlessly over
several years; subjects were not examined by the authors
in their terminal states.
Fig. 4 Common neuropathological features of the 3 cases of HDLS studied here. Spheroids were abundant (a) primarily in the deeper white
matter without affecting the short association fibers; b spheroids had a heterogeneous distribution as is evident by comparing the left and right
side of the image; c focal very dense clusters of spheroids were seen (Case #3, orbital frontal cortex). d Microglia were not diffusely distributed
and were of two distinct populations. Many microglia had morphologies indicative of (e) activated phagocytic macrophages that were CD68
positive and Iba1 negative with unusually ramified morphologies (f) while others were Iba1 positive microglia with more simple morphologies
(Case #2, anterior corpus callosum). Occasionally, additional pathologies included (g) patches of calcifications (Case #2, blue-black splotchy areas
in the anterior corpus callosum) and (h) irregular neuronal accumulations of pathological tau (Case #3, anterior cingulate). i Spheroids could also
be visualized by tau, ubiquitin and α-synuclein antibodies (not shown here as well as by anti-neurofilament antibodies (shown here for Case #1 in
the angular gyrus). Antibodies and stains used: (a-c) 22c11, (d-e) CD68, (f) Iba1, (g) H&E, (h) PHF1, (i) RMO24.9
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Neuropathology
Each case showed abundant white matter Aβ precursor
protein (APP) positive spheroids that were heteroge-
neously distributed in subcortical regions (Figs. 3 and
4a-c). These spheroids were also observed by neurofila-
ment (Fig. 4i), tau and ubiquitin antibodies and H&E
(not shown). The spheroids were more numerous in
deep white matter with the U-fibers relatively spared
(Fig. 4a). Phagocytic cells (macrophages and microglia)
were also heterogeneously distributed in the subcortical
white matter and these cells showed highly varied and
distinctly unusual morphologies. The most distinctive
morphology was characteristic of activated phagocytic
macrophages (Fig. 4d-e) that were strongly positive for
CD68, but not Iba1 positive. Other, Iba1 positive micro-
glia had a more classic microglia shape (Fig. 4f ). Promin-
ent spongiosis in neocortical regions was another
common feature. Neither TDP-43 nor α-synuclein inclu-
sions were observed.
Case #1’s gross examination revealed severe frontal
and temporal atrophy with severe ventricular enlarge-
ment and a 1092 g brain weight. Microscopically, besides
the numerous spheroids (Fig. 3a), additional pathology
included obvious neuronal loss and degeneration of long
axonal projections, extensive cell loss and gliosis with
relative sparing of the granule cells in the hippocampus,
rare Aβ plaques and focal cortical amyloid angiopathy
(CAA), but no neurofibrillary tangles (NFTs). Case #2
had moderate frontal atrophy with mild ventricular en-
largement and weighed 1338 g. There were focal areas
of dystrophic calcification and mild demyelination in the
corpus callosum (Fig. 4g) and entorhinal cortex that
were not apparent in the MRI. Rare ballooned neurons
were noted in the cingulate, along with tau-positive
grains and neurites in limbic areas, occasional tau-
positive coiled bodies, mild CAA without Aβ plaques
and NFTs in the medial temporal lobe. Case #3 had
mild, diffuse atrophy with mild ventricular enlargement
and weighed 1278 g. The limbic regions and brainstem
were relatively spared, although spheroids were observed
in the medulla. Similar to Case #2, irregular, tau-positive
ballooned neurons were also noted in the cingulate
(Fig. 4h) while no Aβ plaques were seen but some NFTs
were present only in the entorhinal cortex.
Conclusions
Abundant white matter spheroids and CD68-positive
macrophages were the predominant pathologies in these
cases. Cases #2 and #3 had rare ballooned neurons,
coiled bodies and tau-positive grains and neurites, which
are found in other tauopathies such as corticobasal de-
generation, progressive supranuclear palsy, Pick’s disease
and argyrophilic grain disease [11]. What role patho-
logical tau plays in HDLS has yet to be determined.
The p.Arg782His mutation has been previously re-
ported in three families from Japan (Case #4) [12], USA
(Case #5) [13] and Korea (Case #6) [14]. The clinical
similarities and differences of our three cases and the
additional published cases with the same mutation are
highlighted in Table 1. Cognitive difficulties were noted
for all cases. Our three patients all presented with slo-
wed movements, as did Case #6 in the Table, but Cases
#4 and #5 did not. Postural instability was also common,
although this was a late symptom for Case #5. The
motor deficits in Cases #4 and #6 were eventually severe,
while the others had relatively mild impairments.
CSF1R is a key regulator of myeloid lineage cells and
microglia in the adult brain [15] and HDLS-associated
CSF1R mutations are all located in the protein’s tyrosine
kinase domain. Experimental evidence indicates that
these mutations cause loss of function [16, 17]. CSF1R
mutations may also result in haploinsufficiency [18]
which, in mice, causes a HDLS-like phenotype [19].
CSF1R’s role as a microglial regulator and the functional
deficits associated with CSF1R mutations supports the
hypothesis that microglia dysfunction may precede the
accumulation of axonal spheroids in HDLS. Here we
present three familial cases with full neuropathological
characterization that demonstrate the range of pathology
and clinical phenotypes that can be seen in individuals
with the same CSF1R mutation. Since the three siblings
studied here were diagnosed clinically with FTD, CBS,
and DLB, our findings underscore the critical import-
ance of genetic testing for establishing a clinical and
pathological diagnosis of HDLS.
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